PMID: 1929323DOI: 10.1128/aac.35.8.1527Aug 1, 1991Paper

Animal models in the evaluation of antimicrobial agents.

Antimicrobial Agents and Chemotherapy
O Zak, T O'Reilly
Get PDF

Abstract

No abstract listed.

References

Animal models in the assessment of antimicrobial agents

Mar 1, 1976·The Journal of Antimicrobial Chemotherapy·F O'Grady

Application of mathematical model to experimental chemotherapy of fatal murine pneumonia.

Feb 1, 1990·Antimicrobial Agents and Chemotherapy·T HishikawaK Matsumoto

Animal models as predictors of the safety and efficacy of antibiotics

Jul 1, 1990·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·O Zak, T O'Reilly

Correlation between pharmacokinetics, pharmacodynamics and efficacy of antibacterial agents in animal models

Jul 1, 1990·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A Dalhoff, U Ullmann

Basic requirements for the toxicity testing of antimicrobial agents

Jul 1, 1990·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·R Bass, T Lehnert

Significance of tissue levels for prediction of antibiotic efficacy and determination of dosage

Jul 1, 1990·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·C Carbon

Discovery and development of new antimicrobial agents.

Jan 1, 1990·Clinical Microbiology Reviews·T D Gootz

Cerebrospinal fluid protein profile in experimental pneumococcal meningitis and its alteration by ampicillin and anti-inflammatory agents.

Jan 1, 1989·The Journal of Infectious Diseases·J L KadurugamuwaO Zak

Impact of the dosage schedule on the efficacy of ceftazidime, gentamicin and ciprofloxacin in Klebsiella pneumoniae pneumonia and septicemia in leukopenic rats

Oct 1, 1989·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·R RoosendaalB M Michel

Dexamethasone treatment for bacterial meningitis in children and adults

Dec 1, 1989·The Pediatric Infectious Disease Journal·N I GirgisM E Kilpatrick

Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models.

Feb 1, 1989·The Journal of Infectious Diseases·J E LeggettW A Craig

Magnetic resonance imaging and dexamethasone therapy for bacterial meningitis.

Mar 1, 1989·American Journal of Diseases of Children·M H LebelG H McCracken

Simulation of human serum pharmacokinetics of ticarcillin-clavulanic acid and ceftazidime in rabbits, and efficacy against experimental Klebsiella pneumoniae meningitis.

May 1, 1989·Antimicrobial Agents and Chemotherapy·L MizenE J Catherall

Dexamethasone therapy for bacterial meningitis. Results of two double-blind, placebo-controlled trials

Oct 13, 1988·The New England Journal of Medicine·M H LebelG H McCracken

Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model

Oct 1, 1988·The Journal of Infectious Diseases·B VogelmanW A Craig

Temocillin efficacy in experimental Klebsiella pneumoniae meningitis after infusion into rabbit plasma to simulate antibiotic concentrations in human serum.

Nov 1, 1988·Antimicrobial Agents and Chemotherapy·G WoodnuttL Mizen

Lessons learned from animal models of osteomyelitis

Jan 1, 1988·Reviews of Infectious Diseases·C W Norden

Role of pharmacokinetics in the outcome of infections.

Mar 1, 1988·Antimicrobial Agents and Chemotherapy·G L Drusano

Dexamethasone in the treatment of experimental Haemophilus influenzae type b meningitis

Feb 1, 1987·The Journal of Infectious Diseases·G A SyrogiannopoulosG H McCracken

Antibiotic therapy of infections due to Pseudomonas aeruginosa in normal and granulocytopenic mice: comparison of murine and human pharmacokinetics

Jan 1, 1986·The Journal of Infectious Diseases·A U GerberB Stalder

Limitations of animal models in predicting beta-lactam efficacy for endocarditis and meningitis

Jul 1, 1986·Reviews of Infectious Diseases·J L Gerberding, M A Sande

Man versus beast: pharmacokinetic scaling in mammals

Nov 1, 1986·Journal of Pharmaceutical Sciences·J Mordenti

Effects of ampicillin and corticosteroids on brain water content, cerebrospinal fluid pressure, and cerebrospinal fluid lactate levels in experimental pneumococcal meningitis

Mar 1, 1985·The Journal of Infectious Diseases·M G TäuberM A Sande

Correlation of antibacterial activities of antibiotics in vitro and in animal models of infection

Jan 1, 1985·The Journal of Antimicrobial Chemotherapy·O ZakM A Sande

Animal scale-up

Oct 1, 1973·Journal of Pharmacokinetics and Biopharmaceutics·R L Dedrick

In vivo evaluation of antibacterial chemotherapeutic substances

Jan 1, 1971·Advances in Applied Microbiology·A K Miller

Integration of selected pharmacologic and microbiologic properties of three new beta-lactam antibiotics: a hypothesis for rational comparison

May 1, 1984·Reviews of Infectious Diseases·G L DrusanoS C Schimpff

Central venous catheter-induced endocarditis: human correlate of the animal experimental model of endocarditis

Nov 1, 1984·Reviews of Infectious Diseases·M M Tsao, D Katz

Prediction of the disposition of beta-lactam antibiotics in humans from pharmacokinetic parameters in animals

Jun 1, 1984·Journal of Pharmacokinetics and Biopharmaceutics·Y SawadaT Iga

Selection of aminoglycoside-resistant variants of Pseudomonas aeruginosa in an in vivo model

Nov 1, 1982·The Journal of Infectious Diseases·A U GerberW A Craig

Scope and limitations of experimental chemotherapy

Apr 15, 1980·Experientia·O Zak

Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics

Apr 1, 1982·Journal of Pharmacokinetics and Biopharmaceutics·H Boxenbaum

❮ Previous
Next ❯

Citations

Explant culture of gastrointestinal tissue: a review of methods and applications

Mar 9, 2011·Cell Biology and Toxicology·Kevin J RandallJohn R Foster

A tissue cage model in calves for studies on pharmacokinetic/pharmacodynamic interactions of antimicrobials

Oct 3, 2003·International Journal of Antimicrobial Agents·Christina GrekoBjörn Bengtsson

Contribution of animal models of infection for the evaluation of the activity of antimicrobial agents

Jul 10, 2008·International Journal of Antimicrobial Agents·N Belmatoug, B Fantin

Comparative efficacies of levofloxacin and ciprofloxacin against Streptococcus pneumoniae in a mouse model of experimental septicaemia

Jul 27, 1999·International Journal of Antimicrobial Agents·C O OnyejiC H Nightingale

In vivo efficacy of continuous infusion versus intermittent dosing of ceftazidime alone or in combination with amikacin relative to human kinetic profiles in a Pseudomonas aeruginosa rabbit endocarditis model

May 1, 2001·The Journal of Antimicrobial Chemotherapy·M A RobauxG Potel

Beige mouse model for Mycobacterium avium complex disease.

Aug 1, 1995·Antimicrobial Agents and Chemotherapy·P R Gangadharam

Neutropenia induced in outbred mice by a simplified low-dose cyclophosphamide regimen: characterization and applicability to diverse experimental models of infectious diseases

Mar 21, 2006·BMC Infectious Diseases·Andres F ZuluagaOmar Vesga

A potent combination microbicide that targets SHIV-RT, HSV-2 and HPV

Apr 18, 2014·PloS One·Larisa KizimaJosé A Fernández-Romero

Preparation and evaluation of ofloxacin-loaded palmitic acid solid lipid nanoparticles.

Apr 7, 2011·International Journal of Nanomedicine·Shuyu XieWenZhong Zhou

Challenges of general safety evaluations of biologics compared to small molecule pharmaceuticals in animal models

Jan 1, 2010·Expert Opinion on Drug Discovery·Rakesh DixitPatricia Clare Ryan

Galleria mellonella infection models for the study of bacterial diseases and for antimicrobial drug testing

Jan 6, 2016·Virulence·C TsaiT Proft

Gallesia integrifolia (Spreng.) Harms: In vitro and in vivo antibacterial activities and mode of action

Mar 8, 2016·Journal of Ethnopharmacology·Karuppusamy ArunachalamDomingos Tabajara de Oliveira Martins

Optimizing Polymyxin Combinations Against Resistant Gram-Negative Bacteria

Dec 10, 2015·Infectious Diseases and Therapy·Phillip J BergenBrian T Tsuji

In vivo antimicrobial activity of marbofloxacin against Pasteurella multocida in a tissue cage model in calves

Aug 11, 2015·Frontiers in Microbiology·Changfu CaoZhenling Zeng

Quinupristin/dalfopristin

Aug 21, 2002·Expert Opinion on Pharmacotherapy·Joseph M Blondeau, Stephen E Sanche

Pharmacodynamics of antibiotics in the respiratory tree

Dec 19, 2003·Expert Opinion on Pharmacotherapy·Eugénie Bergogne-Bérézin

Larva of the greater wax moth, Galleria mellonella, is a suitable alternative host for studying virulence of fish pathogenic Vibrio anguillarum

Jun 24, 2015·BMC Microbiology·Stuart McMillanAndrew P Desbois

Pharmacokinetics and pharmacodynamics of 'old' polymyxins: what is new?

Sep 11, 2012·Diagnostic Microbiology and Infectious Disease·Phillip J BergenJian Li

Animal models of external traumatic wound infections.

Jun 28, 2011·Virulence·Tianhong DaiMichael R Hamblin

Antibiotic efficacy varies based on the infection model and treatment regimen for Pseudomonas aeruginosa.

Oct 19, 2019·The European Respiratory Journal·Cristina CiganaAlessandra Bragonzi

Combinations of antifungal agents in therapy--what value are they?

Sep 18, 2004·The Journal of Antimicrobial Chemotherapy·Manuel Cuenca-Estrella

Cryptosporidium parvum and mucosal immunity in neonatal cattle

Nov 15, 2001·Animal Health Research Reviews·C R Wyatt

Oral Candida in Patients with Fixed Orthodontic Appliance: In Vitro Combination Therapy

Jul 8, 2017·BioMed Research International·Wisam AlhamadiHussam W Al-Humadi

New solvent options for in vivo assays in the Galleria mellonella larvae model

Aug 28, 2019·Virulence·Beatriz Suay-GarcíaMaría Teresa Pérez-Gracia

Primary rodent infection models for testing antibacterial compound efficacy in vivo

Jan 1, 2006·Current Protocols in Pharmacology·Andrea Marra, Dennis Girard

Impetigo Animal Models: A Review of Their Feasibility and Clinical Utility for Therapeutic Appraisal of Investigational Drug Candidates

Oct 18, 2020·Antibiotics·Solomon AbrhaJackson Thomas

Anti-microbial Effects In Vitro and In Vivo of Alstonia scholaris.

Jan 4, 2021·Natural Products and Bioprospecting·Yun-Li ZhaoXiao-Dong Luo

Development of biomimetic antimicrobial platelet-like particles comprised of microgel nanogold composites

Nov 24, 2020·Regenerative Engineering and Translational Medicine·Erin P SproulAshley C Brown

Preclinical Research in Glycogen Storage Diseases: A Comprehensive Review of Current Animal Models.

Dec 23, 2020·International Journal of Molecular Sciences·Aitana Almodóvar-PayáTomàs Pinós

Animal models of invasive mycoses.

Mar 2, 2021·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Henrik Elvang Jensen

Systemic exposure, tissue distribution, and disease evolution of a high solubility ciprofloxacin-aluminum complex in a murine model of septicemia induced by salmonella enterica serotype Enteritidis

Jan 1, 2013·Molecular Pharmaceutics·Susana Andrea BredaMaria Eugenia Olivera

The current state of animal models in research: A review

Oct 19, 2019·International Journal of Surgery·N Bryce RobinsonMario Gaudino

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Related Papers

In vitro models for processes involved in intestinal absorption

(opens in new tab)
Expert Opinion on Drug Metabolism & Toxicology
Florian NigschSilvia Miret
ContactHelpTerms Privacy Cookies
© 2022 Meta ULC. All rights reserved